Scheme 1. Formation of Pyrido[1,2-a]benzimidazoles
Compared with those containing transition metals, hy-
pervalent iodine(III) reagents in many cases serve as
complementary and even superior promoters of CꢀC6
and Cꢀheteroatom7 bond forming reactions. For instance,
Antonchick8a and Chang8b et al. independently developed
rt hypervalent iodine(III)-mediated intramolecular CꢀH
amidationreactionsfortheefficientsynthesisofcarbazoles.
In addition, it has been shown that hypervalent iodine
reagents are powerful oxidants in CꢀC bond cleavage of
O-containing substances, such as glycols,9 epoxides,10 and
olefins.11 Despite these successes, hypervalent iodine(III)
reagent promoted demethylenation reactions, involving
CꢀC and CꢀN bond cleavage followed by intramolecular
CꢀN bond formation, remain undocumented.
Owing to their remarkable biological activities, includ-
ing antibacterial,12 antitumor,13 and antiviral,14 many
methods15ꢀ17 have been developed for the preparation of
multisubstituted pyrido[1,2-a]benzimidazoles. Among the
approaches devised, Pd-catalyzed intramolecular CꢀN
coupling reactions of N-ortho-bromophenyl-2-aminopyr-
idines in refluxing DMF are the premier methods used to
construct this scaffold (Scheme 1).16 Independently, we17a
and Maes et al.17b also developed improved methods
through intramolecular CꢀH amination. However, both
of these processes need to be performed at temperatures
over 120 °C and their substrate scope is limited in that
substrates bearing electron-withdrawing substituents on
the pyridine ring are far less reactive.
In continuing studies, we envisaged that hypervalent
iodine(III)-promoted intramolecularCꢀH amination reac-
tions18 could be employed to prepare 6H-pyrido[1,2-a]-
quinazolines starting with readily accessible N-benzyl-2-
aminopyridines.19 In fact, utilizing N-benzyl-2-aminopyridine
1a as the substrate in the presence of 2.2 equiv of phenyliodine
diacetate (PIDA) in HFIP at rt, this reaction leads to the
formation of pyrido[1,2-a]benzimidazole 2a in 85% yield. To
further improve the yield of 2a, the reaction conditions were
optimized by screening additives, solvents, and other hyper-
valent iodines (see Supporting Information (SI) for details).
The optimized conditions involving the use of 2.2 equiv of
PhI(OPiv)2 in HFIP at rt in air were identified (Scheme 2).
Substrates containing a variety of para-substituents,
regardless of their electron-donating (Me and OMe) or
electron-withdrawing (F, Cl, Br, and I) properties, under-
go efficient (84%ꢀ96%) reactions that generate the
(6) (a) Samanta, R.; Lategahn, J.; Antonchick, A. P. Chem. Commun.
2012, 48, 3194. (b) Wang, J.; Yuan, Y.; Xiong, R.; Zhang-Negrerie, D.;
Du, Y.; Zhao, K. Org. Lett. 2012, 14, 2210. (c) Kita, Y.; Morimoto, K.;
Ito, M.; Ogawa, C.; Goto, A.; Dohi, T. J. Am. Chem. Soc. 2009, 131,
1668. (d) Dohi, T.; Ito, M.; Morimoto, K.; Iwata, M.; Kita, Y. Angew.
Chem., Int. Ed. 2008, 47, 1301. (e) Dohi, T.; Morimoto, K.; Maruyama,
A.; Kita, Y. Org. Lett. 2006, 8, 2007. (f) Dohi, T.; Morimoto, K.;
Kiyono, Y.; Maruyama, A.; Tohma, H.; Kita, Y. Chem. Commun. 2005,
41, 2930. (g) Node, M.; Kodama, S.; Hamashima, Y.; Baba, T.;
Hamamichi, N.; Nishide, K. Angew. Chem., Int. Ed. 2001, 40, 3060.
(7) For recent examples, see: (a) Souto, J. A.; Martınez, C.; Velilla, I.;
~
Muniz, K. Angew. Chem., Int. Ed. 2013, 52, 1324. (b) Farid, U.; Wirth, T.
~
Angew. Chem., Int. Ed. 2012, 51, 3462. (c) Souto, J. A.; Zian, D.; Muniz,
K. J. Am. Chem. Soc. 2012, 134, 7242. (d) Souto, J. A.; Becker, P.;
~
Iglesias, A.; Muniz, K. J. Am. Chem. Soc. 2012, 134, 15505. (e) Samanta,
R.; Bauer, J. O.; Strohmann, C.; Antonchick, A. P. Org. Lett. 2012, 14,
5518. (f) Ban, X.; Pan, Y.; Lin, Y.; Wang, S.; Du, Y.; Zhao, K. Org.
~
Biomol. Chem. 2012, 10, 3606. (g) Lishchynskyi, A.; Muniz, K. Chem.;
ꢀ
Eur. J. 2012, 18, 2212. (h) Souto, J. A.; Gonzalez, Y.; Iglesias, A.; Zian,
~
D.; Lishchynskyi, A.; Muniz, K. Chem.;Asian J. 2012, 7, 1103.
(8) (a) Antonchick, A. P.; Samanta, R.; Kulikov, K.; Lategahn, J.
Angew. Chem., Int. Ed. 2011, 50, 8605. (b) Cho, S. H.; Yoon, J.; Chang,
S. J. Am. Chem. Soc. 2011, 133, 5996.
(9) (a) Angyal, S. J.; Young, R. J. J. Am. Chem. Soc. 1959, 81, 5467.
(b) Pausacker, K. H. J. Chem. Soc. 1953, 107.
(10) Spyroudis, S.; Varvoglis, A. J. Org. Chem. 1981, 46, 5231.
(11) (a) Miyamoto, K.; Sei, Y.; Yamaguchi, K.; Ochiai, M. J. Am.
Chem. Soc. 2009, 131, 1382. (b) Miyamoto, K.; Tada, N.; Ochiai, M.
J. Am. Chem. Soc. 2007, 129, 2772. (c) Ochiai, M.; Miyamoto, K.;
Yokota, Y.; Suefuji, T.; Shiro, M. Angew. Chem., Int. Ed. 2005, 44, 75.
(d) Ochiai, M.; Miyamoto, K.; Shiro, M.; Tomoyuki, O.; Yamaguchi, K.
J. Am. Chem. Soc. 2003, 125, 13006. (e) Koser, G. F.; Wettach, R. H.;
Troup, J. M.; Frenz, B. A. J. Org. Chem. 1976, 41, 3609.
(12) Hammad, M.; Mequid, A.; Ananni, M. E.; Shafik, N. Egypt. J.
Chem. 1987, 29, 5401.
(16) Iwaki, T.; Yasuhara, A.; Sakamoto, T. J. Chem. Soc., Perkin
Trans. 1 1999, 1505.
(17) (a) Wang, H.; Wang, Y.; Peng, C.; Zhang, J.; Zhu, Q. J. Am.
Chem. Soc. 2010, 132, 13217. (b) Masters, K.-S.; Rauws, T. R. M.;
Yadav, A. K.; Herrebout, W. A.; Van der Veken, B.; Maes, B. U. W.
Chem.;Eur. J. 2011, 17, 6315.
(18) (a) Huang, J.; He, Y.; Wang, Y.; Zhu, Q. Chem.;Eur. J. 2012,
18, 13964. (b) Alla, S. K.; Kumar, R. K.; Sadhu, P.; Punniyamurthy, T.
Org. Lett. 2013, 15, 1334. (c) Qu, G.-R.; Liang, L.; Niu, H.-Y.; Rao,
W.-H.; Guo, H.-M.; Fossey, J. S. Org. Lett. 2012, 14, 4494.
(19) (a) Maiti, D.; Fors, B. P.; Henderson, J. L.; Nakamura, Y.;
Buchwald, S. L. Chem. Sci. 2011, 2, 57. (b) Rodriguez, S.; Qu, B.;
Haddad, N.; Reeves, D. C.; Tang, W.; Lee, H.; Krishnamurthy, D.;
Senanayake, C. H. Adv. Synth. Catal. 2011, 353, 533. (c) Huang, M.; Lin,
X.; Zhu, X.; Peng, W.; Xie, J.; Wan, Y. Eur. J. Org. Chem. 2011, 4523. (d)
Lundgren, R. J.; Sappong-Kumankumah, A.; Stradiotto, M. Chem.;
Eur. J. 2010, 16, 1983. (e) Liu, Z.-J.; Vors, J.-P.; Gesing, E. R. F.; Bolm,
C. Adv. Synth. Catal. 2010, 352, 3158.
(13) (a) Badaway, E.; Kappe, T. Eur. J. Med. Chem. 1995, 30, 327.
ꢁ
(b) Hranjec, M.; Piantanida, I.; Kralj, M.; Suman, L.; Pavelı, K.;
Karminski-Zamola, G. J. Med. Chem. 2008, 51, 4899. (c) Hranjec, M.;
ꢁ
Kralj, M.; Piantanida, I.; Sedı, M.; Suman, L.; Pavelı, K.; Karminski-
Zamola, G. J. Med. Chem. 2007, 50, 5696.
(14) Kotovskaya, S. K.; Baskakova, Z. M.; Charushin, V. N.;
Chupakhin, O. N.; Belanov, E. F.; Bormotov, N. I.; Balakhnin, S. M.;
Serova, O. A. Pharm. Chem. J. 2005, 39, 574.
(15) (a) Liubchak, K.; Nazarenko, K.; Tolmachev, A. Tetrahedron
2012, 68, 2993. (b) Wu, Z.; Huang, Q.; Zhou, X.; Yu, L.; Li, Z.; Wu, D.
Eur. J. Org. Chem. 2011, 27, 5242. (c) Zhao, D.; Hu, J.; Wu, N.; Huang,
X.; Qin, X.; Lan, J.; You, J. Org. Lett. 2011, 13, 6516. (d) Venkatesh, C.;
Sundaram, G. S. M.; Ila, H.; Junjappa, H. J. Org. Chem. 2006, 71, 1280.
(d) Kutsumura, N.; Kunimatsu, S.; Kagawa, K.; Otani, T.; Saito, T.
Synthesis 2011, 3235.
Org. Lett., Vol. 15, No. 13, 2013
3477